Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Erythropoiesis in the Rps19 disrupted mouse: Analysis of erythropoietin response and biochemical markers for Diamond-Blackfan anemia

Författare

Summary, in English

The human ribosomal protein S19 gene (RPS19) is mutated in approximately 20% of patients with Diamond-Black fan anemia (DBA), a congenital disease with a specific defect in erythropoiesis. The clinical expression of DBA is highly variable, and subclinical phenotypes may be revealed by elevated erythrocyte deaminase (eADA) activity only. In mice, complete loss of Rps19 results in early embryonic lethality whereas Rps19(+/-) mice are viable and without major abnormalities including the hematopoietic system. We have performed a detailed analysis of the Rps19(+/-) mice. We estimated the Rps19 levels in hematopoictic tissues and we analyzed erythrocyte deaminase activity and globin isoforms which are used as markers for DBA. The effect of a disrupted Rps19 allele on a different genetic background was investigated as well as the response to erythropoietin (EPO). From our results, we argue that the loss of one Rps19 allele in mice is fully compensated for at the transcriptional level with preservation of erythropoiesis. (c) 2005 Elsevier Inc. All rights reserved.

Publiceringsår

2006

Språk

Engelska

Sidor

259-264

Publikation/Tidskrift/Serie

Blood Cells, Molecules & Diseases

Volym

36

Issue

2

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Hematology

Nyckelord

  • erythropoiesis
  • Diamond-Blackfan anemia
  • Rps19
  • mouse model

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1096-0961